2019
DOI: 10.22336/rjo.2019.5
|View full text |Cite
|
Sign up to set email alerts
|

The histaminergic control of the iridal vascular tone in rats and its influencing by topical administration of olopatadine and ranitidine

Abstract: Objective. We evaluated the histamine’s role in regulating the iris vasomotricity in rats, using as a research tool topical olopatadine, a selective H1 blocker, which is indicated for the treatment of allergic conjunctivitis and ranitidine, a selective H2 blocker mainly used for the treatment of peptic ulcer disease. Methods. Two groups of six Wistar rats anesthetized with ketamine 200 mg/kg body weight were used. They received distilled water in conjunctival instillations, i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 15 publications
(17 reference statements)
0
6
0
Order By: Relevance
“…The used substances were: Distilled water (Zentiva SA, Romania), Ketamine, 10% solution (CP-Ketamin 10%, CP-Pharma, Germany, veterinary medicine), Olopatadine, ophthalmic solution 1 mg/mL (Opatanol ® 1 mg/mL, ophthalmic drops, Alcon, United Kingdom) -H1 antagonist, Ranitidine, 25 mg/mL solution for injection (Arnetin ® 50 mg/2 mL, solution for injection, Medochemie, Cyprus) -H2 antagonist, Histamine hydrochloride, purity powder > 99% (Sigma). The experimental protocol was described in previously published papers [12]. 15 minutes after the rats were anesthetized with ketamine 10%, we began to record the right eye of each animal.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The used substances were: Distilled water (Zentiva SA, Romania), Ketamine, 10% solution (CP-Ketamin 10%, CP-Pharma, Germany, veterinary medicine), Olopatadine, ophthalmic solution 1 mg/mL (Opatanol ® 1 mg/mL, ophthalmic drops, Alcon, United Kingdom) -H1 antagonist, Ranitidine, 25 mg/mL solution for injection (Arnetin ® 50 mg/2 mL, solution for injection, Medochemie, Cyprus) -H2 antagonist, Histamine hydrochloride, purity powder > 99% (Sigma). The experimental protocol was described in previously published papers [12]. 15 minutes after the rats were anesthetized with ketamine 10%, we began to record the right eye of each animal.…”
Section: Methodsmentioning
confidence: 99%
“…The experimental data published so far did not present a complete picture of the effects of histamine on the vasomotricity of the anterior ocular segment, in vivo. Most studies used isolated organ experimental models, and a few in vivo models [1,5,12,20]. However, regarding the role of the histaminergic system on vascular control of the ocular posterior segment, there are some human studies showing the vasodilating effect of histamine through H1 receptors, more in the choroidal territory than in the retinal territory [18,23,26].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Promethazine, an antipsychotic with antihistamine activity, has been shown to produce an idiopathic swelling of the lens that could increase the risk of angle-closure glaucoma. Topical administration of ranitidine produces vasoconstriction in both the arterioles and the venules of the iris, suggesting a predominant role of histamine H 2 R in the vasculature of the iris [52].…”
Section: The Histaminergic System At Ocular Levelmentioning
confidence: 99%
“…Histamine H 1 Rs are localized on horizontal cells and in a small number of amacrine cells, whereas histamine H 2 Rs appear closely associated with synaptic ribbons inside cone pedicles [41]. Histaminergic H 1 and H 2 receptors in the iris arterioles and H 2 receptors in the iridal venules modulate vascular tone in rats [52]. Moreover, several ocular hypertensive effects have been reported in chronic glaucoma patients following the use of cimetidine and ranitidine, two H 2 R antagonists, for peptic ulcer treatment [53]; on the contrary, recent studies have failed to demonstrate the significant action of topical administered H 2 blockers on IOP in humans [54].…”
Section: The Histaminergic System At Ocular Levelmentioning
confidence: 99%